» Articles » PMID: 38213616

Infection of Tumor Cells with Mimics Immunogenic Cell Death and Elicits Tumor-specific Immune Responses

Overview
Journal PNAS Nexus
Specialty General Medicine
Date 2024 Jan 12
PMID 38213616
Authors
Affiliations
Soon will be listed here.
Abstract

Some properties of -infected cells overlap with immunogenic cell death. In this study, we demonstrated that intracellular infection of melanoma with induced high immunogenicity in melanoma cells, leading to antitumor effects with melanoma-antigen-specific T-cell responses. Murine B16F10 melanoma cells were infected with tdTomato-expressing attenuated (VNP20009; VNP-tdT), triggering massive cell vacuolization. VNP-tdT-infected B16F10 cells were phagocytosed efficiently, which induced the activation of antigen-presenting cells with CD86 expression in vitro. Subcutaneous coimplantation of uninfected and VNP-tdT-infected B16F10 cells into C57BL/6 mice significantly suppressed tumor growth compared with the implantation of uninfected B16F10 cells alone. Inoculation of mice with VNP-tdT-infected B16F10 cells elicited the proliferation of melanoma-antigen (gp100)-specific T cells, and it protected the mice from the second tumor challenge of uninfected B16F10 cells. These results suggest that -infected tumor cells acquire effective adjuvanticity, leading to ideal antitumor immune responses.

Citing Articles

Salmonella-based therapeutic strategies: improving tumor microenvironment and bringing new hope for cancer immunotherapy.

He X, Guo J, Bai Y, Sun H, Yang J Med Oncol. 2024; 42(1):27.

PMID: 39666238 DOI: 10.1007/s12032-024-02578-0.


Hyperdifferentiated murine melanoma cells promote adaptive anti-tumor immunity but activate the immune checkpoint system.

Ando Y, Horiuchi Y, Hatazawa S, Mataki M, Nakamura A, Murakami T Oncoimmunology. 2024; 14(1):2437211.

PMID: 39648330 PMC: 11633153. DOI: 10.1080/2162402X.2024.2437211.


Attenuated Salmonella typhimurium L forms suppress tumor growth and promote apoptosis in murine ovarian tumors.

Zhang Y, Tang Z, Shao Y, Yue X, Chu Y, Chen D Sci Rep. 2024; 14(1):16045.

PMID: 38992056 PMC: 11239651. DOI: 10.1038/s41598-024-66898-x.

References
1.
Fridman W, Zitvogel L, Sautes-Fridman C, Kroemer G . The immune contexture in cancer prognosis and treatment. Nat Rev Clin Oncol. 2017; 14(12):717-734. DOI: 10.1038/nrclinonc.2017.101. View

2.
Fang H, Ang B, Xu X, Huang X, Wu Y, Sun Y . TLR4 is essential for dendritic cell activation and anti-tumor T-cell response enhancement by DAMPs released from chemically stressed cancer cells. Cell Mol Immunol. 2013; 11(2):150-9. PMC: 4003380. DOI: 10.1038/cmi.2013.59. View

3.
Tesniere A, Schlemmer F, Boige V, Kepp O, Martins I, Ghiringhelli F . Immunogenic death of colon cancer cells treated with oxaliplatin. Oncogene. 2009; 29(4):482-91. DOI: 10.1038/onc.2009.356. View

4.
Horiuchi Y, Takagi A, Kobayashi N, Moriya O, Nagai T, Moriya K . Effect of the infectious dose and the presence of hepatitis C virus core gene on mouse intrahepatic CD8 T cells. Hepatol Res. 2013; 44(10):E240-E252. DOI: 10.1111/hepr.12275. View

5.
Yuzhakova D, Shirmanova M, Serebrovskaya E, Lukyanov K, Druzhkova I, Shakhov B . CT26 murine colon carcinoma expressing the red fluorescent protein KillerRed as a highly immunogenic tumor model. J Biomed Opt. 2015; 20(8):88002. DOI: 10.1117/1.JBO.20.8.088002. View